HB1016 updates South Dakota's controlled substances law to create a specific definition of "chemically derived cannabinoid" that excludes certain cannabis-based products like naturally decarboxylated cannabinoids, non-psychoactive cannabinoids, and topical creams from stricter drug scheduling rules. This means some cannabis products won't be automatically classified as illegal controlled substance analogues just because their chemical structure was modified, giving manufacturers and users more clarity about which products are regulated.
This bill does not directly amend codified state law.
Signed by the Governor H.J. 304
Delivered to the Governor H.J. 232
Signed by the President S.J. 186
Signed by the Speaker H.J. 210
Senate Do Pass Passed, YEAS 34, NAYS 0. S.J. 163
Senate Deferred to another day S.J. 147
Health and Human Services Do Pass Passed, YEAS 7, NAYS 0. S.J. 5
Health and Human Services Scheduled for hearing S.J. 1
Senate Referred to Senate Health and Human Services S.J. 93
First Reading Senate S.J. 83
House of Representatives Do Pass Passed, YEAS 61, NAYS 7. H.J. 107
Health and Human Services Do Pass Passed, YEAS 13, NAYS 0.
Health and Human Services Scheduled for hearing H.J. 1
First read in House and referred to House Health and Human Services H.J. 12
Do Pass
Health and Human Services — Do Pass
Do Pass
Health and Human Services — Do Pass